Ocular Therapeutix (OCUL) added ~21% in the premarket on Thursday after the French publication La Lettre reported that Sanofi (SNY) is readying an improved takeover offer to acquire the U.S. eye ...

Ocular Therapeutix shares are trading higher Thursday after reports suggested Sanofi is preparing a revised bid for the ...

"For SNY, there is a need to replace Dupixent revenue which is facing (loss of exclusivity) in 2031 (consensus estimates ...

Sanofi may rebid for Ocular Therapeutix, Inc. to boost retinal therapeutics ahead of Dupixent patent expiry. Click for more ...

Ocular Therapeutix (OCUL) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price ...

Patients with psoriasis are at increased risk for cataracts, uveitis, dry eye disease, glaucoma, retinal vein occlusion (RVO) ...

Signs and symptoms of ocular surface disease could be significantly reduced within 4 days after treatment with shelf-stable ...

Chicago Atlantic announced its role as sole arranger and administrative agent in the closing of a $16.5 million senior ...

Ocular motor apraxia (OMA) is a neurological condition resulting in an inability to turn the eyes voluntarily in a horizontal manner. Ocular Motor Apraxia is known by a variety of terms. OMA is ...

Ocular larva migrans is a rare inflammatory condition of the eye caused by local reactions to the larva of Toxocara species. These are roundworms which infest dogs and cats as their definitive hosts.